Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03202550 · ClinicalTrials.gov registry record · Phase 4
Oral Sedation During Cervical Dilator Placement
A Phase 4 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 27
- Enrollment target
NCT03202550: Completed Phase 4 study, sponsored by Johns Hopkins University.
NCT03202550 is a Phase 4 study that has completed, run by Johns Hopkins University. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03202550, a Phase 4 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 27 participants
- Enrollment target
Study Summary
This will be a randomized, double-blind, placebo-controlled trial involving 2 arms. It will be comparing the effects of placebo compared to 1 mg oral lorazepam/5 mg oral oxycodone on pain scores during cervical dilator placement prior to dilation and evacuation (D\&E).
Interventions
- DRUG Placebo Comparator
- DRUG Oxycodone and Lorazepam (Active Comparator)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2017-06-28 |
| Est. Completion | 2019-05-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03202550
The ClinicalTrials.gov registry entry for NCT03202550 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Comparator is the first listed.
NCT03202550 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03202550 about?
NCT03202550 is a clinical study titled "Oral Sedation During Cervical Dilator Placement". This will be a randomized, double-blind, placebo-controlled trial involving 2 arms. It will be comparing the effects of placebo compared to 1 mg oral lorazepam/5 mg oral oxycodone on pain scores during cervical dilator placement prior to dilation and evacuation (D\&E).
What is the current status of trial NCT03202550?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 27 participants. The study started on 2017-06-28. Estimated completion is 2019-05-28.
What interventions are being tested in trial NCT03202550?
The interventions under investigation include: Placebo Comparator (DRUG), Oxycodone and Lorazepam (Active Comparator) (DRUG).
Who is sponsoring clinical trial NCT03202550?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.